These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16142725)

  • 1. Heterogeneity of tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Siebert et al.
    Todd I; Nowlan ML; Drewe E; Tighe PJ; Powell RJ
    Arthritis Rheum; 2005 Sep; 52(9):2952; author reply 2952-3. PubMed ID: 16142725
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell surface expression of TNFRI in tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Nedjai et al.
    Todd I; Tighe P; Rebelo S; Powell R
    Arthritis Rheum; 2008 Jul; 58(7):2213-4; author reply 2214-5. PubMed ID: 18576329
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dodé et al.
    Drewe E; Lanyon PC; Powell RJ
    Arthritis Rheum; 2003 Jun; 48(6):1768-9; author reply 1769-70. PubMed ID: 12794852
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists.
    Wildemann B; Rudofsky G; Kress B; Jarius S; Konig F; Schwenger V
    Neurology; 2007 May; 68(20):1742-4. PubMed ID: 17360963
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
    Aganna E; Aksentijevich I; Hitman GA; Kastner DL; Hoepelman AI; Posma FD; Zweers EJ; McDermott MF
    Eur J Hum Genet; 2001 Jan; 9(1):63-6. PubMed ID: 11175303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis.
    Reuss R; Pohle S; Retzlaff K; Hemberger J; Oschmann P
    Neuroimmunomodulation; 2009; 16(3):171-6. PubMed ID: 19246939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J; Bazan HE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
    Siebert S; Amos N; Lawson TM
    Rheumatology (Oxford); 2008 Feb; 47(2):228-9. PubMed ID: 18056150
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
    D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
    Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R92Q TNFRSF1A mutation and Behçet's disease: comment on the article by Amoura et al.
    Direskeneli H; Saruhan-Direskeneli G
    Arthritis Rheum; 2005 Aug; 52(8):2583; author reply 2583-4. PubMed ID: 16059903
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression.
    Siebert S; Fielding CA; Williams BD; Brennan P
    FEBS Lett; 2005 Sep; 579(23):5193-8. PubMed ID: 16162344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of CD28-CD27-NKG2D+ effector memory T cells and predominant Th1-type response during febrile attacks in tumor necrosis factor-associated periodic syndrome.
    Holle JU; Capraru D; Csernok E; Gross WL; Lamprecht P
    Isr Med Assoc J; 2006 Feb; 8(2):142-4. PubMed ID: 16544745
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.).
    Grayfer L; Belosevic M
    Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent oral ulceration: aphthous-like ulcers in periodic syndromes.
    Scully C; Hodgson T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):845-52. PubMed ID: 18805719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
    Sacré K; Brihaye B; Lidove O; Papo T; Pocidalo MA; Cuisset L; Dodé C
    J Rheumatol; 2008 Feb; 35(2):357-8. PubMed ID: 18260167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.